The Global Alzheimer's Platform Foundation, based in Washington, DC, is a leading organization dedicated to accelerating the development of treatments for Alzheimer's disease. With a network of over 100 clinical research partners worldwide, GAP-Net Sites collaborate to lower the cost and duration of clinical trials, while promoting diversity in research to ensure inclusivity. Through their flagship services, including GAP Participant Services and the Inclusive Research Initiative, GAP strives to connect researchers and participants, providing high-touch support and resources to bridge the gap between sites, community-based organizations, studies, and volunteers.
Recognizing the urgent need for innovative clinical trial strategies, GAP is at the forefront of pioneering approaches to accelerate the search for a cure. Their commitment to advancing Alzheimer's research is evident in their support of GAP-enabled trials and initiation of GAP-sponsored studies. With a focus on early detection and intervention, GAP works tirelessly to improve brain health and make a difference in the lives of the 6 million Americans currently living with Alzheimer's disease.
Generated from the website